MOUNJARO KWIKPEN tirzepatide 12.5mg solution for injection in pre-filled pen (UK)
Section 19A approved medicine
MOUNJARO KWIKPEN tirzepatide 12.5mg solution for injection in pre-filled pen (UK)
Section 19A approval holder
Eli Lilly Australia Pty Ltd ABN 39 000 233 992
Phone
1800 454 559
Approved until
Status
Current
Medicines in short supply/unavailable
MOUNJARO tirzepatide 12.5 mg/0.5 mL solution for injection vial - ARTG 407052
Indication(s)
MOUNJARO is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:
- as monotherapy when metformin is not tolerated or contraindicated.
- in addition to other medicinal products for the treatment of type 2 diabetes.
Images
